An official American Thoracic Society/European Respiratory Society statement: research questions in chronic obstructive pulmonary disease
BR Celli, M Decramer, JA Wedzicha… - American journal of …, 2015 - atsjournals.org
Background: Chronic obstructive pulmonary disease (COPD) is a leading cause of
morbidity, mortality, and resource use worldwide. The goal of this Official American Thoracic …
morbidity, mortality, and resource use worldwide. The goal of this Official American Thoracic …
Variability and standardization of quantitative imaging: monoparametric to multiparametric quantification, radiomics, and artificial intelligence
Radiological images have been assessed qualitatively in most clinical settings by the expert
eyes of radiologists and other clinicians. On the other hand, quantification of radiological …
eyes of radiologists and other clinicians. On the other hand, quantification of radiological …
Chronic obstructive pulmonary disease phenotypes: the future of COPD
Significant heterogeneity of clinical presentation and disease progression exists within
chronic obstructive pulmonary disease (COPD). Although FEV1 inadequately describes this …
chronic obstructive pulmonary disease (COPD). Although FEV1 inadequately describes this …
The development of phosphorescent probes for in vitro and in vivo bioimaging
Phosphorescence is a process that slowly releases the photoexcitation energy after the
removal of the excitation source. Although transition metal complexes and purely organic …
removal of the excitation source. Although transition metal complexes and purely organic …
Imaging of lung function using hyperpolarized helium‐3 magnetic resonance imaging: review of current and emerging translational methods and applications
During the past several years there has been extensive development and application of
hyperpolarized helium‐3 (HP 3He) magnetic resonance imaging (MRI) in clinical respiratory …
hyperpolarized helium‐3 (HP 3He) magnetic resonance imaging (MRI) in clinical respiratory …
Impact of exacerbations on emphysema progression in chronic obstructive pulmonary disease
N Tanabe, S Muro, T Hirai, T Oguma… - American journal of …, 2011 - atsjournals.org
Rationale: Low-attenuation areas assessed by computed tomography reflect the extent of
pathological emphysema and correlate with airflow limitation and mortality in patients with …
pathological emphysema and correlate with airflow limitation and mortality in patients with …
Quantitative computed tomography in COPD: possibilities and limitations
Chronic obstructive pulmonary disease (COPD) is a heterogeneous disease that is
characterized by chronic airflow limitation. Unraveling of this heterogeneity is challenging …
characterized by chronic airflow limitation. Unraveling of this heterogeneity is challenging …
Biomarkers in chronic obstructive pulmonary disease
SR Rosenberg, R Kalhan - Translational Research, 2012 - Elsevier
Chronic obstructive pulmonary disease (COPD) is a complex disease with multiple
phenotypes that cannot be identified through measurement of lung function alone. The …
phenotypes that cannot be identified through measurement of lung function alone. The …
Spatial and temporal heterogeneity of regional lung ventilation determined by electrical impedance tomography during pulmonary function testing
B Vogt, S Pulletz, G Elke, Z Zhao… - Journal of applied …, 2012 - journals.physiology.org
Electrical impedance tomography (EIT) is a functional imaging modality capable of tracing
continuously regional pulmonary gas volume changes. The aim of our study was to …
continuously regional pulmonary gas volume changes. The aim of our study was to …
Sputum matrix metalloproteinase-12 in patients with chronic obstructive pulmonary disease and asthma: relationship to disease severity
R Chaudhuri, C McSharry, J Brady, I Donnelly… - Journal of Allergy and …, 2012 - Elsevier
BACKGROUND: Matrix metalloproteinase (MMP)-12 has been implicated in the
pathogenesis of both chronic obstructive pulmonary disease (COPD) and asthma. The …
pathogenesis of both chronic obstructive pulmonary disease (COPD) and asthma. The …